PHARMAORIGIN ApS: Financial statements 2014
CVR: 29178291
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -558,000 compared with DKK -937,714 the year before. Equity in the 2014 report amounted to DKK 4,310,000. The solvency ratio was 77.2%.
- Profit/Loss
- DKK -558,000
- Equity
- DKK 4,310,000
- Total Assets
- DKK 5,584,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -558 t. | 4.3 mio. | - |
| 2013 | 0 | 0 | -938 t. | -132 t. | - |
| 2012 | - | - | -149 t. | 806 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
PHARMAORIGIN ApS has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK -937,714.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees (2008). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity in the 2025 report amounted to DKK 1,477,000.